Covered recipient · General Payments record
ADAM LAUBACH SPENGLER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$6,516.29
- Reported across 280 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $814.75 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $357.61 | 19 |
| RxSight Inc | $211.42 | 6 |
| Alcon Laboratories Inc | $81.31 | 4 |
| BIOTISSUE HOLDINGS INC. | $58.98 | 1 |
| Harrow Eye, LLC | $28.31 | 1 |
| Rayner Intraocular Lenses Limited | $26.28 | 1 |
| Carl Zeiss Meditec USA, Inc. | $18.41 | 1 |
| Sight Sciences, Inc. | $17.97 | 1 |
| Tarsus Pharmaceuticals, Inc. | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.07 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146447 | CMS |
| ABBVIE INC. | $9.10 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146449 | CMS |
| ABBVIE INC. | $8.93 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146451 | CMS |
| ABBVIE INC. | $16.56 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146453 | CMS |
| ABBVIE INC. | $23.90 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146455 | CMS |
| ABBVIE INC. | $10.85 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146457 | CMS |
| ABBVIE INC. | $114.06 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146459 | CMS |
| ABBVIE INC. | $4.93 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146461 | CMS |
| ABBVIE INC. | $26.16 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146463 | CMS |
| ABBVIE INC. | $12.67 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146465 | CMS |
| ABBVIE INC. | $30.97 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146467 | CMS |
| ABBVIE INC. | $9.10 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146469 | CMS |
| ABBVIE INC. | $4.32 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146471 | CMS |
| ABBVIE INC. | $32.03 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146473 | CMS |
| ABBVIE INC. | $10.51 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146475 | CMS |
| ABBVIE INC. | $12.79 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146477 | CMS |
| ABBVIE INC. | $6.78 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146479 | CMS |
| ABBVIE INC. | $6.03 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146481 | CMS |
| ABBVIE INC. | $6.85 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106146483 | CMS |
| Alcon Vision LLC | $19.16 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558129 | CMS |
| Alcon Vision LLC | $18.73 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558127 | CMS |
| Alcon Vision LLC | $15.69 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558125 | CMS |
| Alcon Vision LLC | $27.73 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558131 | CMS |
| BIOTISSUE HOLDINGS INC. | $58.98 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148767376 | CMS |
| Carl Zeiss Meditec USA, Inc. | $18.41 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153262936 | CMS |
| Harrow Eye, LLC | $28.31 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145617336 | CMS |
| Rayner Intraocular Lenses Limited | $26.28 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076275122 | CMS |
| RxSight Inc | $18.37 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144228728 | CMS |
| RxSight Inc | $12.86 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144228730 | CMS |
| RxSight Inc | $31.71 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144228732 | CMS |
| RxSight Inc | $14.11 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144228734 | CMS |
| RxSight Inc | $122.10 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144228736 | CMS |
| RxSight Inc | $12.27 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144228738 | CMS |
| Sight Sciences, Inc. | $17.97 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151920905 | CMS |
| Tarsus Pharmaceuticals, Inc. | $14.46 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139134032 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.